Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus
- 1 March 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (3) , 1153-1155
- https://doi.org/10.1128/aac.01351-07
Abstract
Two investigational anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) β-lactams, ceftaroline (a cephalosporin) and ME1036 (a carbapenem), were subjected to susceptibility testing by reference broth microdilution methods using 152 strains of community-acquired MRSA from the United States (47 medical centers). Ceftaroline and ME1036 were 64- and >128-fold more potent than ceftriaxone, respectively. All isolates had the Panton-Valentine leukocidin genes and staphylococcal cassette chromosome mec type IV, while 67.8% of isolates displayed pulsed-field gel electrophoresis clonal type USA300-0114.Keywords
This publication has 13 references indexed in Scilit:
- In Vivo Efficacy of Ceftaroline (PPI-0903), a New Broad-Spectrum Cephalosporin, Compared with Linezolid and Vancomycin against Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus in a Rabbit Endocarditis ModelAntimicrobial Agents and Chemotherapy, 2007
- Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacyExpert Opinion on Investigational Drugs, 2007
- The molecular evolution of methicillin-resistant Staphylococcus aureusClinical Microbiology & Infection, 2007
- Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue InfectionsAnnals of Internal Medicine, 2006
- Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical StrainsAntimicrobial Agents and Chemotherapy, 2005
- Comparison of activities of β-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strainJournal of Infection and Chemotherapy, 2005
- In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2004
- In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599Journal of Infection and Chemotherapy, 2004
- Involvement of Panton-Valentine Leukocidin--Producing Staphylococcus aureus in Primary Skin Infections and PneumoniaClinical Infectious Diseases, 1999
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998